FOXO Technologies Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Mark White

Algemeen directeur

US$257.5k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.2yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

CEO

Mark White (64 yo)

1.2yrs

Tenure

US$257,500

Compensatie

Mr. Mark Brian White has been the Chief Executive Officer, President and Director of Touchpoint Group Holdings, Inc. (formerly known as One Horizon Group, Inc.) since September 8, 2017 and serves as its Ac...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Mark White	Interim CEO & Director	1.2yrs	US$257.50k	geen gegevens
Seamus Lagan	Director	less than a year	geen gegevens	geen gegevens
Trevor Langley	Director	less than a year	geen gegevens	geen gegevens
Bret Barnes	Independent Chairman of the Board & Member of Scientific Advisory Board	3yrs	US$744.08k	0.061% $ 1.1k
Peter Laird	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Hui Shen	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Francis deWolf	Director	less than a year	geen gegevens	geen gegevens

0.8yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van FOXO wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw bestuur.

FOXO Technologies Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Less than half of directors are independent

FOXO Technologies Inc. Announces Appointment of Francis Colt Dewolf to the Board of Directors

FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors

FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors

High number of new and inexperienced directors

Recent updates

FOXO Technologies Inc. announced that it has received $0.297033 million in funding from Kr8 ai Inc.

FOXO Technologies Inc. announced that it has received $0.2565 million in funding

FOXO Technologies Inc. (NYSEAM:FOXO) completed the acquisition of Rennova Community Health, Inc. from Rennova Health, Inc.(OTCPK:RNVA) for $20 million.

FOXO Technologies Inc. announced delayed 10-Q filing

FOXO Technologies Regains Compliance with NYSE American

FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Reaffirms Commitment to Regaining Compliance with NYSE American

Less than half of directors are independent

FOXO Technologies Inc. (NYSEAM:FOXO) entered into the Stock Exchange Agreement to acquire Myrtle Recovery Centers from Rennova Health, Inc. (OTCPK:RNVA) for $0.5 million.

FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

FOXO Technologies Inc. announced delayed annual 10-K filing

FOXO Technologies Inc. announced that it has received $0.1422 million in funding

FOXO Technologies Inc. (NYSEAM:FOXO) entered into a non-binding agreement to acquire M2i Global, Inc. (OTCPK:MTWO).

FOXO Technologies Inc. (NYSEAM:FOXO) entered into a non-binding agreement to acquire M2i Global, Inc. (OTCPK:MTWO).

Less than half of directors are independent

FOXO Technologies Inc. announced that it has received $0.45747 million in funding

FOXO Technologies Inc. Announces Appointment of Francis Colt Dewolf to the Board of Directors

FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors

FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors

FOXO Technologies Inc. announced delayed 10-Q filing

FOXO Technologies Inc. Plans to Unveil its New Direct-To-Consumer (DTC) App, the VITHAR™ AI Health Coach

FOXO Technologies Inc. Unveils Plans for New Direct-To Consumer Offering Combining the Company's Epigenetic Data with the Power of Ai

High number of new and inexperienced directors

FOXO Technologies Inc. Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers

FOXO Technologies Inc. Appoints Martin Ward as Interim Chief Financial Officer

FOXO Technologies Inc. announced that it has received $0.7435 million in funding

FOXO Technologies Inc. announced that it has received $0.2935 million in funding

FOXO Technologies Announces NYSE American Acceptance of Compliance Plan

FOXO Technologies Announces NYSE American Acceptance of Compliance Plan

FOXO Technologies Inc. announced that it expects to receive $0.2935 million in funding

FOXO Technologies Announces Receipt of Second Notice of Non-Compliance from NYSE American

FOXO Technologies Inc. to Report Q2, 2023 Results on Aug 10, 2023

FOXO Technologies Inc. Reduces Employee Headcount via Layoffs

FOXO Technologies Inc. Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis

New major risk - Market cap size

FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

FOXO Technologies Inc. announced that it has received $3.806125 million in funding

First quarter 2023 earnings released: US$0.33 loss per share (vs US$6.09 loss in 1Q 2022)

FOXO Technologies Inc., Annual General Meeting, May 26, 2023

Full year 2022 earnings released: US$3.46 loss per share (vs US$19.06 loss in FY 2021)

High number of new and inexperienced directors

FOXO Technologies Inc. Appoints Taylor Fay as Chief Operating Officer

Foxo Technologies Inc. Announces Resignation of Jon Sabes as Member of the Board of Directors

FOXO Technologies Inc. announced delayed 10-Q filing

Less than half of directors are independent

FOXO Technologies Announces Resignation of Chief Product Officer, Erin Sharoni

FOXO Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

Less than half of directors are independent

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd